Life Sciences Research for Lifelong Health

Kathryn Balmanno

Kathy comes from Sarf London and spent 7 years at the Institute of Cancer Research in Sutton before moving to the Cancer Research Unit at The University of Newcastle Upon Tyne. During this time she completed a part time degree in Cell and Molecular Biology and an MPhil by research, working on various aspects of anti-cancer drug development. Kathy joined the Cook laboratory in 1997 as its founder member! She has worked on a range of projects and is interested in how nutritional cues integrate with growth factor signalling pathways to control cell survival and cell proliferation. Kathy’s outside interests include jogging, reading, music and film.

Latest Publications

Maintenance of the marginal-zone B cell compartment specifically requires the RNA-binding protein ZFP36L1.

Newman R, Ahlfors H, Saveliev A

Nature immunology
1529-2916: (2017)

PMID: 28394372

RNA-binding proteins ZFP36L1 and ZFP36L2 promote cell quiescence.

Galloway A, Saveliev A, Łukasiak S

Science (New York, N.Y.)
352 1095-9203:453-9 (2016)

PMID: 27102483

Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation.

Lochhead PA, Clark J, Wang LZ

Cell cycle (Georgetown, Tex.)
15 1551-4005:506-18 (2016)

PMID: 26959608

Maternal DNA Methylation Regulates Early Trophoblast Development.

Branco MR, King M, Perez-Garcia V

Developmental cell
36 1878-1551:152-63 (2016)

PMID: 26812015

MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road.

Caunt CJ, Sale MJ, Smith PD

Nature reviews. Cancer
15 1474-1768:577-92 (2015)

PMID: 26399658

Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome.

Ashford AL, Dunkley TP, Cockerill M

Cellular and molecular life sciences : CMLS
1420-9071: (2015)

PMID: 26346493